Comments
Loading...
Benitec Biopharma (BNTC) Forecast
NewsEarningsBenitec Biopharma (BNTC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBenitec Biopharma (NASDAQ:BNTC) Stock Quotes, Forecast and News Summary
Benitec Biopharma Stock (NASDAQ: BNTC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Benitec Biopharma (BNTC) stock?
You can purchase shares of Benitec Biopharma (NASDAQ:BNTC) through any online brokerage.
Who are Benitec Biopharma (BNTC) competitors?
Other companies in Benitec Biopharma’s space includes: Korro Bio (NASDAQ:KRRO), Monopar Therapeutics (NASDAQ:MNPR), Tango Therapeutics (NASDAQ:TNGX), Tevogen Bio Holdings (NASDAQ:TVGN) and Eledon Pharma (NASDAQ:ELDN).
What is the forecast, or price target, for Benitec Biopharma (BNTC) stock?
Benitec Biopharma has a consensus price target of $21.88.
What is the current price for Benitec Biopharma (BNTC)?
The stock price for Benitec Biopharma (NASDAQ: BNTC) is $11.795 last updated February 21, 2025 at 10:14 AM EST.
Does Benitec Biopharma (BNTC) pay a dividend?
There are no upcoming dividends for Benitec Biopharma.
When is Benitec Biopharma (NASDAQ:BNTC) reporting earnings?
Benitec Biopharma’s Q3 earnings are confirmed for Monday, May 12, 2025.
Is Benitec Biopharma (BNTC) going to split?
There is no upcoming split for Benitec Biopharma.
What sector and industry does Benitec Biopharma (BNTC) operate in?
Benitec Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.